What is the ROCE (Return on Capital Employed) of BioCorRx this year?
The ROCE of BioCorRx is 0.38 undefined this year.
BioCorRx ROCE 2024
BioCorRx ROCE
0.38
Ticker
BICX
ISIN
US09073C2052
WKN
A1XERB
In 2024, BioCorRx's return on capital employed (ROCE) was 0.38, a -34.63% increase from the 0.58 ROCE in the previous year.
BioCorRx Aktienanalyse
What does BioCorRx do?
The company BioCorRx Inc is a US-American company that was founded in 2008 and is headquartered in Anaheim, California. BioCorRx specializes in the development and marketing of innovative treatment methods for alcohol and drug dependency. The history of BioCorRx began with the introduction of its flagship product, the BioCorRx Recovery Program, which is based on a novel medical technology called Naltrexone/Buprenorphine Implant. Unlike traditional methods of treating alcohol and drug addiction, which typically rely on medication and psychotherapeutic support, the BioCorRx Recovery Program is an implantable, long-term treatment system that continuously delivers the active ingredient Naltrexone or Buprenorphine into the patient's body. The idea behind this is that the active ingredients prevent withdrawal symptoms and thereby reduce the risk of relapse. In recent years, BioCorRx has expanded its product portfolio and expanded its business activities to new segments in order to further drive the company's growth. This includes, for example, the field of telemedicine services, which allow BioCorRx to offer its treatment technology and medical services through online communication. Telemedicine services such as virtual patient consultation or online group therapy programs are particularly in demand in times of COVID-19. Another focus of BioCorRx is the management of medical personnel. Studies have shown that good patient care and counseling heavily influence the success of treatment. BioCorRx has now also developed its own platform that eases and improves the management, training, and monitoring of medical staff. BioCorRx also utilizes the concept of franchise systems to market its products and services. The franchise system offers medical professionals and organizations working in the field of addiction treatment the opportunity to open their own BioCorRx clinic and offer the company's products and services in their local market. Each clinic is advised and supported by BioCorRx and must adhere to certain standards and quality criteria. In the future, BioCorRx plans to further diversify its product offering and develop new technologies to improve treatment options for alcohol and drug dependents. An example of such a technology is medication based on Ibogaine. BioCorRx has already started initial research in this direction and is actively working on pre-clinical studies. Overall, BioCorRx is a company that primarily focuses on innovative technologies for the treatment of addiction. The company has experienced substantial growth in recent years by expanding its product range and customer base, and focusing on the areas of telemedicine, personnel management, and franchise systems. With its forward-thinking technologies and strong emphasis on quality and patient satisfaction, BioCorRx is expected to continue playing an important role in addiction treatment in the years to come. BioCorRx ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling BioCorRx's Return on Capital Employed (ROCE)
BioCorRx's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing BioCorRx's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
BioCorRx's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in BioCorRx’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about BioCorRx stock
How has the ROCE (Return on Capital Employed) of BioCorRx developed compared to the previous year?
The ROCE of BioCorRx has increased by -34.63% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of BioCorRx?
A high Return on Capital Employed (ROCE) indicates that BioCorRx has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of BioCorRx?
A low ROCE (Return on Capital Employed) can indicate that BioCorRx has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from BioCorRx impact the company?
An increase in the ROCE of BioCorRx can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of BioCorRx affect the company?
A decrease in ROCE of BioCorRx can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of BioCorRx?
Some factors that can affect BioCorRx's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of BioCorRx so important for investors?
The ROCE of BioCorRx is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can BioCorRx take to improve the ROCE?
To improve the ROCE, BioCorRx can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does BioCorRx pay?
Over the past 12 months, BioCorRx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioCorRx is expected to pay a dividend of 0 USD.
What is the dividend yield of BioCorRx?
The current dividend yield of BioCorRx is .
When does BioCorRx pay dividends?
BioCorRx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioCorRx?
BioCorRx paid dividends every year for the past 0 years.
What is the dividend of BioCorRx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is BioCorRx located?
BioCorRx is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioCorRx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioCorRx from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.
When did BioCorRx pay the last dividend?
The last dividend was paid out on 9/10/2024.
What was the dividend of BioCorRx in the year 2023?
In the year 2023, BioCorRx distributed 0 USD as dividends.
In which currency does BioCorRx pay out the dividend?
The dividends of BioCorRx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioCorRx
Our stock analysis for BioCorRx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioCorRx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
